Dr. Fredrik Piehl discusses his paper, "Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis". Show references: https://jamanetwork.com/journals/jamaneurology/fullarticle/2796552 This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Fredrik Piehl discusses his paper, "Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis". Show references: https://jamanetwork.com/journals/jamaneurology/fullarticle/2796552 This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Rituximab for New-Onset Generalized Myasthenia Gravis

The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.

Share Rituximab for New-Onset Generalized Myasthenia Gravis

Sign up to save your podcasts

Rituximab for New-Onset Generalized Myasthenia Gravis

Rituximab for New-Onset Generalized Myasthenia Gravis

More shows like Neurology Minute

JAMA Editors' Summary

Neurology® Podcast

NEJM This Week

Practical Neurology Podcast

JAMA Clinical Reviews

JAMA Neurology Author Interviews

JAMA Medical News

Neurology Today in 5

Annals On Call Podcast

Navigating Neuropsychology

The Clinical Problem Solvers

Harrison's PodClass: Internal Medicine Cases and Board Prep

Neurology Exam Prep Podcast

The Curious Clinicians

Continuum Audio